Suven Life Sciences secures five (5) Product Patents in China, Israel, Mexico, Singapore and Sri Lan

nDimensionsIP
Sep 22, 2015
1 min read

Suven Life Sciences had announced the grant of five patents in various countries. These patents include the class of selective 5 HT (Hydroxytryptamine) compounds relating to the treatment of cognitive impairment leading to neurodegenerative diseases

#Hydroxytryptamine #SuvenLifeSciences

Recent Posts

See All

General Motors gets Indian patent related to powertrain technology

General Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...

Trademarks Office: Abandonment orders kept in abeyance

Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...

Delhi High Court: No “irreconcilable conflict” between the Competition Act and the Patents Act

The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...

nDimensions IP

Suven Life Sciences secures five (5) Product Patents in China, Israel, Mexico, Singapore and Sri Lan

Recent Posts

Comments

Working Hours

Contact Us